Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-17-001230
Filing Date
2017-07-19
Accepted
2017-07-19 17:25:49
Documents
1
Period of Report
2017-07-17

Document Format Files

Seq Description Document Type Size
1 form4-07192017_020738.html 4  
1 form4-07192017_020738.xml 4 3972
  Complete submission text file 0001415889-17-001230.txt   5330
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4560 HORTON STREET,M/S R-422 EMERYVILLE CA 94608
Business Address
SOLAND DANIEL B (Reporting) CIK: 0001318485 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50768 | Film No.: 17972914